00820nam a2200253 i 4500991002517389707536070606s2006 it ||| | ita d8873980260b13539474-39ule_instDip.to Fisicaeng530.4453.6.54LC QC718Ossi, Paolo Maria625915Plasmi per superfici /Paolo Maria OssiMilano :Polipress,2006x, 199 p. ;24 cmPlasma physics.b1353947406-06-0706-06-07991002517389707536LE006 53.6.5 OSS12006000160537le006pE25.00-l- 02020.i1448026806-06-07Plasmi per superfici1222669UNISALENTOle00606-06-07ma -itait 0004282oam 2200625I 450 991079999070332120230725020027.00-429-13066-X1-283-00453-497866130045361-4398-1017-610.1201/b10279 (CKB)2560000000058169(EBL)665619(OCoLC)707067824(SSID)ssj0000469781(PQKBManifestationID)11312409(PQKBTitleCode)TC0000469781(PQKBWorkID)10526998(PQKB)11393182(MiAaPQ)EBC665619(Au-PeEL)EBL665619(CaPaEBR)ebr10447931(CaONFJC)MIL300453(EXLCZ)99256000000005816920180331d2011 uy 0engur|n|---|||||txtccrHandbook of adaptive designs in pharmaceutical and clinical development /edited by Annpey Pong, Shein-Chung ChowBoca Raton :CRC Press,2011.1 online resource (475 p.)Description based upon print version of record.1-4398-1016-8 Includes bibliographical references and index.Front cover; Contents; Preface; Editors; Contributors; Chapter 1. Overview of Adaptive Design Methods in Clinical Trials; Chapter 2. Fundamental Theory of Adaptive Designs with Unplanned Design Change in Clinical Trials with Blinded Data; Chapter 3. Bayesian Approach for Adaptive Design; Chapter 4. The Impact of Protocol Amendments in Adaptive Trial Designs; Chapter 5. From Group Sequential to Adaptive Designs; Chapter 6. Determining Sample Size for Classical Designs; Chapter 7. Sample Size Reestimation Design with Applications in Clinical TrialsChapter 8. Adaptive Interim Analyses in Clinical TrialsChapter 9. Classical Dose-Finding Trial; Chapter 10. Improving Dose-Finding: A Philosophic View; Chapter 11. Adaptive Dose-Ranging Studies; Chapter 12. Seamless Phase I/II Designs; Chapter 13. Phase II/III Seamless Designs; Chapter 14. Sample Size Estimation/Allocation for Two-Stage Seamless Adaptive Trial Designs; Chapter 15. Optimal Response-Adaptive Randomization for Clinical Trials; Chapter 16. Hypothesis-Adaptive Design; Chapter 17. Treatment Adaptive Allocations in Randomized Clinical Trials: An OverviewChapter 18. Integration of Predictive Biomarker Diagnostics into Clinical Trials for New Drug DevelopmentChapter 19. Clinical Strategy for Study Endpoint Selection; Chapter 20. Adaptive Infrastructure; Chapter 21. Independent Data Monitoring Committees; Chapter 22. Targeted Clinical Trials; Chapter 23. Functional Genome-Wide Association Studies of Longitudinal Traits; Chapter 24. Adaptive Trial Simulation; Chapter 25. Efficiency of Adaptive Designs; Chapter 26. Case Studies in Adaptive Design; Chapter 27. Good Practices for Adaptive Clinical Trials; Back coverThis comprehensive guide offers a unified presentation of the principles and methodologies in adaptive design and analysis. It gives a well-balanced summary of current regulatory perspectives and recently developed statistical methods in this area. The handbook provides some insight regarding early phase and later phase adaptive designs. With a focus on the implementation of adaptive methods in clinical trials, it introduces the concepts of role, responsibility, function, and activity of a data safety monitoring board (DSMB) when applying these methods. Other important topics covered in detail include regulatory perspectives and logistics issues in applying adaptive design methods--Provided by publisher.Clinical trialsHandbooks, manuals, etcDrugsResearchMethodologyHandbooks, manuals, etcClinical trialsDrugsResearchMethodology615.5072/4Pong Annpey1588269Chow Shein-Chung1955-254512MiAaPQMiAaPQMiAaPQBOOK9910799990703321Handbook of adaptive designs in pharmaceutical and clinical development3877636UNINA